Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 11, 2009, Pages 1663-1670

  Holmberg, K ^a   Tonnel, A B ^b   Dreyfus, I ^c   Olsson, P ^d   Cougnard, J ^c   Mesbah, K ^c   Devillier, P ^e  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Schering Plough   (France)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UPRES EA 220   (France)

Author keywords

Desloratadine; Nasal congestion; Persistent allergic rhinitis; Rhinoconjunctivitis Quality of Life Questionnaire

Indexed keywords

DESLORATADINE; PLACEBO;

ADULT; AGED; ARTICLE; ASTHMA; CAT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE BLIND PROCEDURE; HEADACHE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; NOSE CONGESTION; PERENNIAL RHINITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOMNOLENCE; TREATMENT RESPONSE;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MALE; MIDDLE AGED; NASAL OBSTRUCTION; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349862278     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02096.x     Document Type: Article

References (34)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 63 (Suppl. 86 8 160.
2. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy 2007 62 (Suppl. 85 17 25.
3. Long AA. Findings from a 1000-patient Internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis. Clin Ther 2007 29 : 342 351.
4. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 2007 62 (Suppl. 85 9 16.
5. Stull DE, Roberts L, Frank L, Heithoff K. Relationship of nasal congestion with sleep, mood and productivity. Curr Med Res Opin 2007 23 : 811 819.
6. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med 2005 4 : 439 446.
7. Storms W. Allergic rhinitis-induced nasal congestion: its impact on sleep quality. Prim Care Respir J 2008 17 : 7 18.
8. de Graaf-in 't Veld T, Koenders S, Garrelds IM, Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1996 98 : 508 513. (Pubitemid 26377915)
9. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM et al. EAACI-GA2LEN-EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006 61 : 316 320.
10. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999 104 : 364 369.
11. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992 305 : 160 164.
12. Juniper E. Measuring health-related quality of life with rhinitis. J Allergy Clin Immunol 1997 99 : S742 S749.
13. Leong KP, Yeakw SCL, Saurajenw ASM, Mokw PKH, Earnestz A, Sioww JK et al. Why generic and disease-specific quality-of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitis. Clin Exp Allergy 2005 35 : 288 298.
14. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991 21 : 77 83.
15. Devillier P, Roche N, Faisy C. Comparative review of the pharmacology and pharmacodynamics of desloratadine, levocetirizine and fexofenadine. Clin Pharmacokinetics 2008 47 : 217 230.
16. Lam HC, Tong MC, Van Hasselt CA. Rhinitis symptoms and quality of life in patients with chronic perennial rhinitis treated with desloratadine. Laryngol Otol 2007 121 : 1151 1155.
17. Kim K, Sussman G, Hebert J, Lumry W, Lutsky B, Gates D. Desloratadine therapy for symptoms associated with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2006 96 : 460 465.
18. Simons FE, Prenner BM, Finn A Jr. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol 2003 111 : 617 622.
19. Allergies in America: A landmark, survey of nasal allergy sufferers. Executive Summary. http://www.myallergiesinamerica.com ; Accessed 3 December 2008.
20. Spector SL, Nicklas RA, Chapman JA, Bernstein IL, Berger WE, Blessing-Moore J et al., the Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; Joint Council of Allergy, Asthma, and Immunology. Symptom severity assessment of allergic rhinitis: part 1. Ann Allergy Asthma Immunol 2003 91 : 105 114.
21. Jaeschke R, Singer J, Guyatt GH. Measurements of health status: ascertaining the minimal clinically important difference. Controlled Clin Trials 1989 10 : 407 415.
22. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996 98 : 843 845.
23. Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008 38 : 19 42.
24. Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M et al. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. Int Immunopharmacol 2005 5 : 1800 1808.
25. Greiff L, Persson CG, Andersson M. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis. Ann Allergy Asthma Immunol 2002 89 : 413 418.
26. Horak F, Stübner UP, Zieglmayer R, Harris AG. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. Allergy 2003 58 : 481 485.
27. Horak F, Stübner UP, Zieglmayer R, Ing D, Harris AG. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 2002 109 : 956 961.
28. Lee DK, Gardiner M, Haggart K, Fujihara S, Lipworth BJ. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. Clin Exp Allergy 2004 34 : 650 653.
29. Berger WE, Lumry WR, Meltzer EO, Pearlman DS. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. Allergy Asthma Proc 2006 27 : 214 223.
30. Meltzer EO, Jalowayski AA, Vogt K, Iezzoni D, Harris AG. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. Ann Allergy Asthma Immunol 2006 96 : 363 368.
31. Nayak AS, Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy 2001 56 : 1077 1080.
32. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004 114 : 838 844.
33. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCI improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1999 83 : 311 317.
34. Salmun LM, Lorber R. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]. BMC Fam Pract 2002 3 : 14.